SLGL (Sol-Gel Technologies Ltd) Gross Sales Margin

Sol-Gel Technologies (SLGL) generates revenue from royalties on its patented silicon microencapsulation, operating at a maturity stage with a current portfolio of dermatological products. This gross profit margin chart clearly demonstrates financial stability, with this metric equal to 0.00. Simultaneously, Sol-Gel Technologies is implementing ESG standards by investing in laboratory energy efficiency and the safe disposal of medical waste.
Comprehensive metric breakdowns and analytics for Sol-Gel (SLGL)

Gross margin measures production efficiency by determining the portion of revenue remaining after direct production costs. The gross margin percentage trend reflects the ability of Sol-Gel Technologies (SLGL) to control cost of goods sold, which in this case is supported by exclusive patents for acne medication microencapsulation, ensuring a technological advantage and a consistently high level of profitability per unit.